- Abstract
- Core Tip
- Article Highlights
- Full Article (PDF)
- Full Article (WORD)
- Full Article (HTML)
- Audio
- PubMed Central
- PubMed
- CrossRef
- Google Scholar
- Similar Articles (16)
- Timeline of Article Publication Processes (1)
- Authors Evaluation (6)
- Article Quality Tracking (0)
- Reference Citation Analysis (System.Threading.Tasks.Task`1[System.Int32])
-
Full Article (HTML) (241) -
Full Article (PDF) (78) -
Send to Friends (0)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Checklist of Responsibilities for the Scientific Editor of This Article
Publishing Process of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5851)
All Articles published online
|
Publishing Process of This Article
|
Jan 14, 2020 (publication date) through Jun 29, 2022
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lv XY, Ding HG, Zheng JF, Fan CL, Li L. Rifaximin improves survival in cirrhotic patients with refractory ascites: A real-world study. World J Gastroenterol 2020; 26(2): 199-218 [PMID: 31988585 DOI: 10.3748/wjg.v26.i2.199] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v26/i2/199.htm |
| Number | Citing Articles |
| 1 |
Bradley Reuter, Jasmohan S. Bajaj. Microbiome. Clinics in Liver Disease 2020; 24(3): 493 doi: 10.1016/j.cld.2020.04.006
|
| 2 |
Thomas H. Tranah, Victoria T. Kronsten, Debbie L. Shawcross. Implications and Management of Cirrhosis‐Associated Immune Dysfunction Before and After Liver Transplantation. Liver Transplantation 2022; 28(4): 700 doi: 10.1002/lt.26353
|
| 3 |
Xiao Yu, Ye Jin, Wangxiao Zhou, Tingting Xiao, Zhongwen Wu, Junwei Su, Hainv Gao, Ping Shen, Beiwen Zheng, Qixia Luo, Lanjuan Li, Yonghong Xiao. Rifaximin Modulates the Gut Microbiota to Prevent Hepatic Encephalopathy in Liver Cirrhosis Without Impacting the Resistome. Frontiers in Cellular and Infection Microbiology 2022; 11 doi: 10.3389/fcimb.2021.761192
|
| 4 |
Igor G. Bakulin, Inna A. Oganezova, Maria I. Skalinskaya, Ekaterina V. Skazyvaeva. Liver cirrosis and complication risk management. Terapevticheskii arkhiv 2021; 93(8): 963 doi: 10.26442/00403660.2021.08.200917
|
| 5 |
Charles E. Gallaher, Debbie L. Shawcross. Management of Multidrug-Resistant Infections in Cirrhosis. Seminars in Liver Disease 2022; 42(02): 173 doi: 10.1055/a-1765-0056
|
| 6 |
Jasmohan S Bajaj, Amirhossein Shamsaddini, Chathur Acharya, Andrew Fagan, Masoumeh Sikaroodi, Edith Gavis, Sara McGeorge, Alexander Khoruts, Michael Fuchs, Richard K Sterling, Hannah Lee, Patrick M Gillevet. Multiple bacterial virulence factors focused on adherence and biofilm formation associate with outcomes in cirrhosis. Gut Microbes 2021; 13(1) doi: 10.1080/19490976.2021.1993584
|
| 7 |
Giacomo Zaccherini, Manuel Tufoni, Mauro Bernardi, Paolo Caraceni. Prevention of Cirrhosis Complications: Looking for Potential Disease Modifying Agents. Journal of Clinical Medicine 2021; 10(19): 4590 doi: 10.3390/jcm10194590
|
| 8 |
Paolo Caraceni, Victor Vargas, Elsa Solà, Carlo Alessandria, Koos Wit, Jonel Trebicka, Paolo Angeli, Rajeshwar P. Mookerjee, François Durand, Elisa Pose, Aleksander Krag, Jasmohan S. Bajaj, Ulrich Beuers, Pere Ginès, Adrià Juanola, Laura Napoleone, Marta Carol, Emma Avitabile, Ann Ma Thu, Marta Cervera, Martina Pérez, Ana Belén Rubio‐Garcia, Alicia Ardiaca, Adriana Vives, Judit Pich, Núria Fabrellas, Giacomo Zaccherini, Maria Teresa Chiappa, César Jiménez, Ester Palacio, Daniela Campion, Tommaso Lanzillotti, Salvatore Piano, Gea Nicolao, Frank Uschner, Sabine Graf_Dirmeier, Claire Francoz, Olivier Roux, Vanessa Esnault, Jeltje Helder, Marites Aban, Konstantin Kazankov, Marko Korenjak, Patrick Kamath, Juan G. Abraldes, Hugh Watson. The Use of Rifaximin in Patients With Cirrhosis. Hepatology 2021; 74(3): 1660 doi: 10.1002/hep.31708
|
| 9 |
Paolo Caraceni, Juan G. Abraldes, Pere Ginès, Phil N. Newsome, Shiv K. Sarin. The search for disease-modifying agents in decompensated cirrhosis: From drug repurposing to drug discovery. Journal of Hepatology 2021; 75: S118 doi: 10.1016/j.jhep.2021.01.024
|
| 10 |
Rui-fang Zhu, Yu-lu Gao, Sue-Ho Robert, Jin-ping Gao, Shi-gui Yang, Chang-tai Zhu. Systematic review of the registered clinical trials for coronavirus disease 2019 (COVID-19). Journal of Translational Medicine 2020; 18(1) doi: 10.1186/s12967-020-02442-5
|